Researcher profile · Semantic Scholar

Vaishnavi Ganti

h-index: 7
Works: 14
Citations: 124

Most-cited papers

Preclinical Characterization of HPN536, a Trispecific, T-Cell–Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors
M. E. Molloy, R. Austin, B. Lemon, W. Aaron +11 more
2020Clinical Cancer Research42 citations
Semantic Scholar
Pharmacokinetic application of a bio-analytical LC-MS method developed for 5-fluorouracil and methotrexate in mouse plasma, brain and urine
Vaishnavi Ganti, E. Walker, S. Nagar
2013Biomedical chromotography18 citations Open access
Semantic Scholar
First-in-human phase I study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager in patients with metastatic castration-resistant prostate cancer (mCRPC).
J. Bendell, L. Fong, M. Stein, T. Beer +9 more
202017 citations
Semantic Scholar
Pharmacokinetic Properties of Humanized IgG1 and IgG4 Antibodies in Preclinical Species: Translational Evaluation
M. Tabrizi, Divas Neupane, Sophia E. Elie, Harish Shankaran +11 more
2019AAPS Journal12 citations
Semantic Scholar
Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer
W. Aaron, R. Austin, Manasi Barath, Evan C Callihan +15 more
2019Therapeutic Agents: Biological10 citations
Semantic Scholar
A phase 1 first‐in‐human study of GS‐0189, an anti‐signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non‐Hodgkin lymphoma (NHL)
M. Narkhede, N. Bartlett, S. Ibrahimi, L. Popplewell +7 more
2023eJHaem7 citations Open access
Semantic Scholar
Integrative Pharmacology: Advancing Development of Effective Immunotherapies
M. Tabrizi, Daping Zhang, Vaishnavi Ganti, Glareh Azadi
2018AAPS Journal7 citations
Semantic Scholar
Statistical analysis of low molecular mass heparin Nanoencapsulation
Vaishnavi Ganti, A. Mengesha, Jacob M. Marszalek, B. Youan
2010Acta Pharmaceutica4 citations Open access
Semantic Scholar
IQ Survey Results on Current Industry Practices: Part 2—Quantitative Evaluations of Immunogenicity Assessment
Susan Richards, I. Winzenborg, D. Luedtke, Tao Niu +10 more
2025Clinical pharmacology and therapy3 citations Open access
Semantic Scholar
Human Emotion Recognition using Bio Signals
Vaishnavi Ganti
2020International Journal of Emerging Trends in Engineering Research3 citations Open access
Semantic Scholar
Abstract CT232: Preliminary results of a phase 1, first-in-human, dose-escalation study of the anti-CCR8 antibody denikitug in participants with advanced solid tumors
B. Bockorny, Christopher T. Chen, J. Ajani, D. Sommerhalder +11 more
2026Cancer Research1 citations
Semantic Scholar
Translational Considerations and Challenges: An Overview
Vaishnavi Ganti, M. Tabrizi
20180 citations
Semantic Scholar
Application of Proof-of-Mechanism Biomarkers (POM) in Design and Development of Biologics Modalities
Glareh Azadi, G. Ayanoglu, Vaishnavi Ganti, Harish Shankaran +1 more
20180 citations
Semantic Scholar
A pharmacokinetic based study to better understand the reported cognitive deficits for 5-fluorouracil and methotrexate in male Swiss-Webster mice
Vaishnavi Ganti
20140 citations
Semantic Scholar

M. E. Molloy

×2

R. Austin×2

W. Aaron×2

A. Seto×2